Medical Xpress May 10, 2021
New variants of the SARS-CoV-2 virus most likely will necessitate the development of more vaccine options in the years ahead, and a biomedical scientist at Iowa State University believes the ‘key’ to that development lies in the way the virus binds to human cells.
Michael Cho, a professor of biomedical sciences at Iowa State, is studying how to develop COVID-19 vaccines that target SARS-CoV-2’s receptor-binding domain, or the part of the virus that docks with the host cellular receptor, angiotensin converting enzyme 2 (ACE2). This docking process allows the virus access to the host’s cells, which leads to infection.
Cho was the lead author of a study recently published in the peer-reviewed scientific journal Frontiers in Immunology detailing the ability...
Today's Sponsors
Today's Sponsor